Can DNA-Guided dosing save lives? new study targets african americans
NCT ID NCT03225820
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving doctors genetic information about their African American patients can help them prescribe the blood thinner warfarin more safely and effectively. Researchers will track how often doctors use this genetic guidance and whether it leads to better health outcomes. The study involves 1,000 African American adults at multiple hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFORMATION SEEKING BEHAVIOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
NOT_YET_RECRUITINGChicago, Illinois, 60611, United States
-
The University of Illinois at Chicago
RECRUITINGChicago, Illinois, 60607, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.